321 related articles for article (PubMed ID: 12866304)
1. [Acute coronary syndrome. The second platelet inhibitor is self-paid].
MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866304
[No Abstract] [Full Text] [Related]
2. [In acute coronary syndrome. Seize platelets with pliers].
MMW Fortschr Med; 2002 Nov; 144(45):61. PubMed ID: 12534069
[No Abstract] [Full Text] [Related]
3. [Dual platelet inhibition with clopidogrel and ASS. Who profits from the combination?].
MMW Fortschr Med; 2003 Jul; 145(27-28):64. PubMed ID: 14587200
[No Abstract] [Full Text] [Related]
4. [Combination is standard. Dual thrombocyte function inhibition in acute coronary syndrome].
MMW Fortschr Med; 2004; 146 Suppl 1():8-9. PubMed ID: 15493411
[No Abstract] [Full Text] [Related]
5. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
MMW Fortschr Med; 2008 Oct; 150(42):52-3. PubMed ID: 18983063
[No Abstract] [Full Text] [Related]
6. [New guidelines in acute coronary syndrome. Clopidogrel for nine months is recommended].
MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440296
[No Abstract] [Full Text] [Related]
7. [After coronary intervention. Which platelet inhibitor for whom?].
Stiefelhagen P
MMW Fortschr Med; 2007 Apr; 149(14):18-9. PubMed ID: 17668756
[No Abstract] [Full Text] [Related]
8. The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
Lindgren P; Stenestrand U; Malmberg K; Jönsson B
Clin Ther; 2005 Jan; 27(1):100-10. PubMed ID: 15763611
[TBL] [Abstract][Full Text] [Related]
9. [Clopidogrel--an expensive thrombocyte inhibitor with a small marginal benefit].
Asplund K
Lakartidningen; 2000 Mar; 97(11):1294-6. PubMed ID: 10771550
[No Abstract] [Full Text] [Related]
10. [New US guidelines. Myocardial infarct is now treated more aggressively].
MMW Fortschr Med; 2002 May; 144(20):64. PubMed ID: 12119892
[No Abstract] [Full Text] [Related]
11. [ASA or clopidogrel?].
Janzon L
Lakartidningen; 2000 May; 97(22):2775-6. PubMed ID: 10900900
[No Abstract] [Full Text] [Related]
12. [Guidelines: acute coronary syndrome (ACS)].
Schwaab B
Z Kardiol; 2004 Aug; 93(8):634-5; author reply 635-6. PubMed ID: 15338151
[No Abstract] [Full Text] [Related]
13. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
[No Abstract] [Full Text] [Related]
15. [Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?].
Rupprecht HJ
MMW Fortschr Med; 2004; 146 Suppl 1():9-10. PubMed ID: 15493412
[No Abstract] [Full Text] [Related]
16. [Anti-platelet drugs (aspirin, ticlopidine, etc)].
Ikeda U
Nihon Rinsho; 2006 Apr; 64(4):743-7. PubMed ID: 16613193
[TBL] [Abstract][Full Text] [Related]
17. Combined antithrombotic therapy for acute coronary syndrome.
Gawaz M; Müller I; Besta F
Semin Vasc Med; 2003 May; 3(2):163-76. PubMed ID: 15199479
[TBL] [Abstract][Full Text] [Related]
18. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Peters RJ; Mehta SR; Fox KA; Zhao F; Lewis BS; Kopecky SL; Diaz R; Commerford PJ; Valentin V; Yusuf S;
Circulation; 2003 Oct; 108(14):1682-7. PubMed ID: 14504182
[TBL] [Abstract][Full Text] [Related]
19. [Cost effectiveness of clopidogrel in acute coronary syndromes without ST-elevation (unstable angina, non-Q AMI)].
Hagymási K
Orv Hetil; 2004 Jun; 145(23):1251-2. PubMed ID: 15323070
[No Abstract] [Full Text] [Related]
20. Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery.
Ray JG; Hamielec CM
Can J Cardiol; 2004 Jun; 20(8):829-30. PubMed ID: 15229768
[No Abstract] [Full Text] [Related]
[Next] [New Search]
